The higher prevalence and the spectrum of severity of ASD reinforce the relevance of dystrophin during neurodevelopment and indicate that pathogenic variants in the dystrophin gene render the brain more susceptible to ASD or even other NDDs or neuropsychiatry phenotypes commonly observed in DMD/BMD patients. This evidence concerns the gene DMD and Becker muscular dystrophy.